Page results
-
Information about the Integrated Cancer Care Service for children and young adults at the RLHIM.
-
What to expect from your neuro-oncology Clinical Nurse Specialist (key worker) at the NHNN
-
This leaflet has written by the administration team at the National Hospital for Neurology and Neurosurgery for outpatients.
-
This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery.
-
This page has been written by the Spasticity Team at the National Hospital for Neurology and Neurosurgery for patients (or their family or carers) who have been referred to our service or are under the care of the team at this hospital.
-
Fibreoptic Endoscopic Evaluation of Swallow (FEES) patient information leaflet
-
The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.
-
This page provides information on examinations using contrast agents in MRI. It is intended for use by patients (or their families or carers) who have been referred to our service for imaging requiring contrast agents.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
Advice on preventing the spread of flu and other respiratory viruses, to keep UCLH patients safe.
File results
-
FOI/2023/0386 - Sickle Cell staffing and patients
-
FOI/2023/0384 - Cyber security attacks 2020-2022
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0083 - Software systems/ suppliers used at Trust